N-alkyl Tryptanthrin Derivatives for IDO Inhibition
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current tryptanthrin derivatives lack effective structures for inhibiting indoleamine 2,3-dioxygenase (IDO), which is crucial for treating tryptophan metabolism disorders such as cancer, Alzheimer's disease, and other conditions, as existing compounds are insufficient in their pharmacological development.
Innovation Solution
Development of novel N-alkyl tryptanthrin derivatives with specific structural modifications, including oxidation, reaction with fluoric isatin or isatin, and substitution processes, to enhance IDO inhibitory activity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If existing tryptanthrin derivatives are used, then the compound structure is simple and easy to manufacture, but the IDO inhibitory activity is insufficient
Solution Approach 1:
The patent applies parameter changes by systematically modifying the chemical structure of tryptanthrin derivatives through varying substituents at different positions (R1-R6 groups). This includes changing alkyl chain lengths, introducing different functional groups, and adjusting molecular weight parameters to optimize IDO inhibitory activity while maintaining reasonable structural complexity
Solution Approach 2:
The patent employs composite material principles by combining tryptanthrin core structure with various substituent groups to create hybrid molecular structures. These composite derivatives integrate the pharmacophore elements of tryptanthrin with additional functional moieties that enhance IDO binding affinity and inhibitory potency
2Reliability
If novel structural modifications are introduced to enhance IDO inhibitory activity, then the pharmacological effectiveness improves, but the manufacturing process becomes more complex
Solution Approach 1:
The patent applies segmentation by dividing the synthesis into distinct modular steps: oxidation of starting materials to form intermediate structures, followed by condensation reactions to build the tryptanthrin core, and finally substitution reactions to install diverse substituent patterns. This segmented approach allows systematic exploration of structure-activity relationships while maintaining manageable synthesis complexity
Solution Approach 2:
The patent employs preliminary action by pre-synthesizing and characterizing key intermediates before final assembly. The oxidation step is performed first to create reactive intermediates that can then be coupled with various substituents, allowing optimization of each transformation independently and simplifying the overall manufacturing process
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The novel tryptanthrin derivatives exhibit high IDO inhibitory activity, providing potential for effective treatment of IDO-mediated diseases like cancer, Alzheimer's, and autoimmune disorders, with potential for new drug development.
Implementation Method 1
oxidizing the compound of formula II to form the compound of formula III
Implementation Method 2
reacting the compound of formula III with fluoric isatin or isatin so as to form the compound of formula IV
Implementation Method 3
substituting the compound of formula IV so as to form the compound of formula I
Data Source
AI summary
An N-alkyl tryptanthrin derivative, a preparation method for same, and an application thereof are provided. The structure of the derivative is as represented by formula I. The N-alkyl tryptanthrin derivative can serve as a highly active IDO inhibitor, for use in preparing a medicament for prevention and/or treatment of a disease having a pathological characteristic of an IDO-mediated tryptophan metabolic pathway.